Description

Book Synopsis
From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.

Table of Contents
Contents: The Pharmaceutical Industry and its Paradigm Shift – The Pharmaceutical Industry and Mergers & Acquisitions – Value Creation in Pharmaceutical M&A and its underlying Value Drivers – The Pharmaceutical Industry and Alliances – Value Creation in Pharmaceutical In-licensings and its underlying Value Drivers – M&A versus In-licensing.

Pharma M&A versus alliances and its underlying

    Product form

    £45.36

    Includes FREE delivery

    RRP £50.40 – you save £5.04 (10%)

    Order before 4pm today for delivery by Sat 27 Jun 2026.

    A Hardback by Heiko Schön

    Out of stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Pharma M&A versus alliances and its underlying by Heiko Schön

      Publisher: Peter Lang AG
      Publication Date: 28/09/2015
      ISBN13: 9783631663813, 978-3631663813
      ISBN10: 3631663811

      Description

      Book Synopsis
      From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.

      Table of Contents
      Contents: The Pharmaceutical Industry and its Paradigm Shift – The Pharmaceutical Industry and Mergers & Acquisitions – Value Creation in Pharmaceutical M&A and its underlying Value Drivers – The Pharmaceutical Industry and Alliances – Value Creation in Pharmaceutical In-licensings and its underlying Value Drivers – M&A versus In-licensing.

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account